Schedule a Free Evaluation: 919-354-3775 contact@extivita.org
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Patient Portal
  • Register
  • Contact
Extivita - Hyperbaric Oxygen Therapy - Durham, NC
  • Home
  • Conditions We Treat
  • Therapies
    • Hyperbaric Oxygen
    • IV Therapy
    • Neurofeedback
    • PEMF
    • Supplements
    • Longevity Challenge
  • Testimonials
  • About
    • News
    • Research
    • Extivita RTP Team
Select Page

The significance of tissue biopsy for fungi in necrotizing otitis externa.

by Extivita | Jun 16, 2018 | Necrotizing Otitis Externa

Abstract: The conventional treatment for necrotizing otitis externa (NOE) is prolonged anti-pseudomonas therapy, with surgical treatment in non-responsive patients. The aim of the present study is to describe the course of management of patients with non-responsive...

Amputation predictors in diabetic foot ulcers treated with hyperbaric oxygen.

by Extivita | Jul 14, 2017 | Diabetic Foot Ulcers

Abstract: Although hyperbaric oxygen therapy (HBOT) has long been used for diabetic foot ulcers (DFUs), its effectiveness is still controversial. The aim of this study was to investigate the efficacy of HBOT in the management of DFUs and identify amputation...

The Successful Treatment of Calciphylaxis with Sodium Thiosulfate and Hyperbaric Oxygen in a Non-dialyzed Patient with Chronic Kidney Disease.

by Extivita | Jul 20, 2016 | Chronic Wounds

Abstract: We present the case of a non-dialyzed patient with chronic kidney disease and biopsy-proven calciphylaxis who presented with painful cutaneous ulcers on both legs. The skin ulcers drastically improved within 6 months after the initiation of hemodialysis,...

Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.

by Extivita | Nov 23, 2015 | Necrotizing Fasciitis

Abstract: New biomarkers are needed to assess the severity of necrotizing soft tissue infection (NSTI) at an early stage and to individualize treatment strategies. We assessed pentraxin-3 (PTX3) as a marker of disease severity and risk of death in patients with NSTI....

Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study.

by Extivita | May 14, 2015 | Necrotizing Fasciitis

Abstract: The mortality and amputation rates are still high in patients with necrotising soft tissue infections (NSTIs). It would be ideal to have a set of biomarkers that enables the clinician to identify high-risk patients with NSTI on admission. The objectives of...
« Older Entries

Search News

 

Archives

 

Contact Us

     

     

     

     

    Professional Memberships

    HBOT Member Logo
    • About Extivita
    • Extivita RTP Team
    • Patient Portal
    • Register
    • Contact
    • Policies
    • Facebook
    • Twitter
    • Instagram
    • RSS
    © 2015-2021 Extivita, LLC
    Hyperbaric Oxygen Therapy (HBOT), Nutritional IV, Neurofeedback Clinic located in Research Triangle Park, North Carolina (RTP, Raleigh, Durham, Chapel Hill).